Alper Özseven

Alper Özseven

Auto-generated profile, based on publicly available information

Alper Özseven

Süleyman Demirel Üniversitesi

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in International Journal of Environmental Science and Technology
Verified
Journal Article
Closed access
PDF file
AÖA. Özseven
A. Özseven
IAI. Akkurt
I. Akkurt
KGK. Günoğlu
K. Günoğlu

1 January 2022 in Open Chemistry
Verified
Journal Article
Open access
PDF file
AÖAlper Özseven
Alper Özseven
In this study, the feasibility of using electronic portal imaging device (EPID) as an analysing equipment for bolus material was evaluated in terms of its dosimetric parameters. Seven superflab bolus material samples, 4 samples of 0.5 cm (S1–S4) and 3 samples of 1 cm thickness (S5–S7), were analysed and compared with tissue equivalent water phantom, which was selected for reference material. Gamma analysis method was used to evaluate the dose distribution of the boluses. In addition, 487,204 point-dose values of each bolus were compared with the point-doses of corresponding reference material by using Spearman’s correlation coefficient analysis. The passing rates varied from 58.3 to 100% for 0.5 cm thick samples, and on the other hand, the passing rates of all the 1 cm thick boluses were 100%. All the correlation coefficient values were above 0.975. The correlation was statistically significant for all the samples (p < 0.001). The correlation coefficient of S4 bolus sample was the highest among the 0.5 cm thick bolus samples with a result of 0.989. Likewise, S5 and S6 bolus samples were the highest among the 1 cm thick ones with a result of 0.995. The results indicated that the material planned to be used as bolus can be evaluated with EPID in daily use.

1 January 2020 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
MUMuhittin Ugurlu
Muhittin Ugurlu
EOEmine Elif Ozkan
Emine Elif Ozkan
AOAlper Ozseven
Alper Ozseven
The purpose of this study was to evaluate the effect of ionizing radiation from high energy X-ray on fluoride release, surface roughness, flexural strength, and surface chemical composition of the materials. The study groups comprised five different restorative materials: Beautifil II, GCP Glass Fill, Amalgomer CR, Zirconomer, and Fuji IX GP. Twenty disk-shaped specimens (8x2 mm) for fluoride release and 20 bar-shaped specimens (25 x 2x 2 mm) for flexural strength were prepared from each material. Each material group was divided into two subgroups: irradiated (IR) and non-irradiated (Non-IR). The specimens from IR groups were irradiated with 1.8 Gy/day for 39 days (total IR = 70.2 Gy). The amount of fluoride released into deionized water was measured using a fluoride ion-selective electrode and ion analyzer after 24 hours and on days 2, 3, 7, 15, 21, 28, 35, and 39 (n = 10). The flexural strength was evaluated using the three-point bending test (n = 10). After the period of measurement of fluoride release, seven specimens (n = 7) from each group were randomly selected to evaluate surface roughness using AFM and one specimen was randomly selected for the SEM and EDS analyses. Data were analyzed with two-way ANOVA and Tukey tests (p = 0.05). The irradiation significantly increased fluoride release and surface roughness for Amalgomer CR and Zirconomer groups (p < 0.05). No significant change in flexural strength of the materials was observed after irradiation (p > 0.05). The ionizing radiation altered the amount of fluoride release and surface roughness of only Amalgomer CR and Zirconomer. The effect could be related to the chemical compositions of materials.

14 April 2021 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Open access
PDF file
AÖAlper Özseven
Alper Özseven
BDBahar Dirican
Bahar Dirican
BACKGROUND: Currently, CBCT system is an indispensable component of radiation therapy units. Because of that, it is important in treatment planning and diagnosis. CBCT is also an crucial tool for patient positioning and verification in image-guided radiation therapy (IGRT). Therefore, it is critical to investigate the patient organ doses arising from CBCT imaging. The purpose of this study is to evaluate patient organ doses and effective dose to patients from three different protocols of Elekta Synergy XVI system for kV CBCT imaging examinations in image guided radiation therapy. MATERIALS AND METHODS: Organ dose measurements were done with thermoluminescent dosimeters in Alderson RANDO male phantom for head & neck (H&N), chest and pelvis protocols of the Elekta Synergy XVI kV CBCT system. From the measured organ dose, effective dose to patients were calculated according to the International Commission on Radiological Protection 103 report recommendations. RESULTS: For H&N, chest and pelvis scans, the organ doses were in the range of 0.03–3.43 mGy, 6.04–22.94 mGy and 2.5–25.28 mGy, respectively. The calculated effective doses were 0.25 mSv, 5.56 mSv and 4.72 mSv, respectively. CONCLUSION: The obtained results were consistent with the most published studies in the literature. Although the doses to patient organs from the kV CBCT system were relatively low when compared with the prescribed treatment dose, the amount of delivered dose should be monitored and recorded carefully in order to avoid secondary cancer risk, especially in pediatric examinations. BACKGROUND: Currently, CBCT system is an indispensable component of radiation therapy units. Because of that, it is important in treatment planning and diagnosis. CBCT is also an crucial tool for patient positioning and verification in image-guided radiation therapy (IGRT). Therefore, it is critical to investigate the patient organ doses arising from CBCT imaging. The purpose of this study is to evaluate patient organ doses and effective dose to patients from three different protocols of Elekta Synergy XVI system for kV CBCT imaging examinations in image guided radiation therapy. MATERIALS AND METHODS: Organ dose measurements were done with thermoluminescent dosimeters in Alderson RANDO male phantom for head & neck (H&N), chest and pelvis protocols of the Elekta Synergy XVI kV CBCT system. From the measured organ dose, effective dose to patients were calculated according to the International Commission on Radiological Protection 103 report recommendations. RESULTS: For H&N, chest and pelvis scans, the organ doses were in the range of 0.03–3.43 mGy, 6.04–22.94 mGy and 2.5–25.28 mGy, respectively. The calculated effective doses were 0.25 mSv, 5.56 mSv and 4.72 mSv, respectively. CONCLUSION: The obtained results were consistent with the most published studies in the literature. Although the doses to patient organs from the kV CBCT system were relatively low when compared with the prescribed treatment dose, the amount of delivered dose should be monitored and recorded carefully in order to avoid secondary cancer risk, especially in pediatric examinations.

22 May 2024 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Open access
PDF file
NKNasıf Fatih Karakuyu
Nasıf Fatih Karakuyu
AÖAlper Özseven
Alper Özseven
SASüleyman Emre Akın
Süleyman Emre Akın
HÇHasan Ekrem Çamaş
Hasan Ekrem Çamaş
OOOzlem Ozmen
Ozlem Ozmen
ÇCÇağla Cengiz
Çağla Cengiz
Radiotherapy (RAD) is a common cancer treatment method, but it can have unintended lung side effects. L-carnitine (LCAR) is an amino acid with antioxidant and anti-inflammatory properties. This study aims to demonstrate the effects of LCAR against radiation-induced acute lung injury and to elucidate its possible protective molecular mechanisms. A total of 32 Wistar albino rats were separated into four groups: control, RAD (10 Gy once on 1st day), RAD + LCAR (intraperitoneally, 200 mg/kg/d, for 10 days), and LCAR. At the end of the experiment, the rats were euthanized, and the lung tissues were collected for histopathological, immunohistochemical, biochemical, and genetic analysis. Emphysema, pronounced hyperemia, increased total oxidant status, and increased caspase-3 and TNF-α immunostainings were all seen in the lung tissues of the RAD group. LCAR treatment reduced these negative effects. In addition, AMPK and SIRT1 gene expressions increased in the RAD + LCAR group compared to the RAD group, while TGF-1ß gene expression decreased. While RAD caused major damage to the lungs of rats, LCAR application reduced this damage through antioxidant, anti-inflammatory, and anti-apoptotic mechanisms. Specifically, LCAR reduced fibrosis while attenuating RAD-induced inflammation and oxidative stress via the AMPK/SIRT1/TGF-1ß pathway. Therefore, LCAR can be considered a supplement to reduce complications associated with RAD. Graphical abstract

1 January 2020 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
EOEmine Elif Ozkan
Emine Elif Ozkan
AOAlper Ozseven
Alper Ozseven
ZCZ. Arda Kaymak Cerkesli
Z. Arda Kaymak Cerkesli
To investigate the predictive value of convenience of rectum dosimetry with Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) dose limits, maximum rectum dose (Dmax), total rectal volume (TVrectum), rectal volume included in PTV (VrectumPTV) on Grade 2-3 acute rectal toxicity for utilization in clinical practice. Numerous previous data have reported frequent acute proctitis after external-beam RT of prostate cancer. Predicting toxicity limited with dose information is inadequate in clinical practice due to comorbidities and medications used. Sixty-four non-metastatic prostate cancer patients treated with IMRT were enrolled. Patients were treated to a total dose of 70-76 Gy. Rectal dose volume histograms (DVH) of all patients were evaluated retrospectively, and a QUANTEC Score between 0 and 5 was calculated for each patient. The correlation between the rectal DVH data, QUANTEC score, TVrectum, VrectumPTV, rectum Dmax and Grade 2-3 rectal toxicity was investigated. In the whole group grade 1, 2 and 3 acute rectal toxicities were 25%, 18.8% and 3.1%, respectively. In the DVH data, rectum doses of all patients were under RTOG dose limits. Statistically significant correlation was found between grade 2-3 rectal toxicity and TVrectum (p = 0,043); however. It was not correlated with QUANTEC score, VrectumPTV and Dmax. Our results were not able to show any significant correlation between increasing convenience with QUANTEC limits and lower rectal toxicity. Conclusively, new dosimetric definitions are warranted to predict acute rectal toxicity more accurately in prostate cancer patients during IMRT treatment.